Siren

Filing Details

13F-HR/A2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-23
Total Holdings
117
Total Value
1772780355
Accession Number
0002005245-25-000008
Form Type
13F-HR/A
Manager Name
Siren
Data Enrichment
96% identified
112 identified5 unidentified

Holdings

117 positions • $1.8B total value
Manager:
Search and click to pin securities to the top
Taysha Gene Therapies, Inc.
Shares:6.5M
Value:$9.1M
% of Portfolio:0.5% ($9.1M/$1.8B)
Cullinan Therapeutics, Inc.
Shares:1.2M
Value:$9.0M
% of Portfolio:0.5% ($9.0M/$1.8B)
CrowdStrike Holdings, Inc.
Shares:25.0K
Value:$8.8M
% of Portfolio:0.5% ($8.8M/$1.8B)
Silence Therapeutics plc
Shares:2.8M
Value:$7.9M
% of Portfolio:0.4% ($7.9M/$1.8B)
Alphabet Inc.
Shares:50.7K
Value:$7.8M
% of Portfolio:0.4% ($7.8M/$1.8B)
Cartesian Therapeutics, Inc.
Shares:563.3K
Value:$7.4M
% of Portfolio:0.4% ($7.4M/$1.8B)
ADOBE INC.
Shares:19.3K
Value:$7.4M
% of Portfolio:0.4% ($7.4M/$1.8B)
Korro Bio, Inc.
Shares:418.8K
Value:$7.3M
% of Portfolio:0.4% ($7.3M/$1.8B)
ServiceNow, Inc.
Shares:9.1K
Value:$7.3M
% of Portfolio:0.4% ($7.3M/$1.8B)
Seer, Inc.
Shares:4.0M
Value:$6.8M
% of Portfolio:0.4% ($6.8M/$1.8B)
PDD Holdings Inc.
Shares:52.9K
Value:$6.3M
% of Portfolio:0.4% ($6.3M/$1.8B)
Spyre Therapeutics, Inc.
Shares:368.6K
Value:$5.9M
% of Portfolio:0.3% ($5.9M/$1.8B)
Gossamer Bio, Inc.
Shares:5.2M
Value:$5.7M
% of Portfolio:0.3% ($5.7M/$1.8B)
Oric Pharmaceuticals, Inc.
Shares:1.0M
Value:$5.6M
% of Portfolio:0.3% ($5.6M/$1.8B)
Upstream Bio, Inc.
Shares:788.5K
Value:$4.8M
% of Portfolio:0.3% ($4.8M/$1.8B)
NVIDIA CORP
Shares:44.4K
Value:$4.8M
% of Portfolio:0.3% ($4.8M/$1.8B)
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD
Shares:28.5K
Value:$4.7M
% of Portfolio:0.3% ($4.7M/$1.8B)
Datadog, Inc.
Shares:47.4K
Value:$4.7M
% of Portfolio:0.3% ($4.7M/$1.8B)
Neumora Therapeutics, Inc.
Shares:4.4M
Value:$4.4M
% of Portfolio:0.2% ($4.4M/$1.8B)
JFrog Ltd
Shares:131.6K
Value:$4.2M
% of Portfolio:0.2% ($4.2M/$1.8B)